Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bifidobacterium breve (1 trial)
bifidobacterium infantis (1 trial)
bifidobacterium longum (1 trial)
Lactobacillus acidophilus (1 trial)
lactobacillus casei (1 trial)
lactobacillus delbrueckii (1 trial)
lactobacillus plantarum (1 trial)
streptococcus salivarius (1 trial)
vsl #3 (1 trial)
Irritable Bowel Syndrome (Phase 3)
Syndrome (Phase 3)
Trials (1 total)
Trial APIs (9 total)